Mathilde Krim Fellowships in Biomedical Research
Request for Proposals
Maximum Funding: $150,000
Performance Period: February 1, 2023 – January 31, 2025
Register for Portal Login and Instructions (REQUIRED) – CLOSED
Letter of Intent Submission – CLOSED
The goal of amfAR’s Mathilde Krim Fellowships in Biomedical Research is to:
- Facilitate the exceptional postdoctoral researcher’s transition to an independent career in HIV/AIDS research within an academic institution or nonprofit organization
- Support two years of postdoctoral biomedical research (phase I)
- Provide the possibility of one additional year of research funding during the first year of an independent research position (phase II)
Applicant Eligibility and Qualifications
- Hold a research or clinical doctorate completed between three and six years prior to August 25, 2022*
- Be positioned to secure an independent research position no later than July 2025
- Be the first author on significant publications in leading peer-reviewed journals
- Propose a line of research sufficiently distinct from the mentor’s own research that it indicates future independence
- Have made oral and poster presentations at major scientific conferences and meetings
- Be affiliated with a nonprofit research institution anywhere in the world
- Be mentored by an experienced investigator at the same institution who: (a) is qualified to oversee the proposed research; (b) has successfully supervised postdoctoral fellows; and (c) is at the associate professor level or higher.
*The three- to six-year eligibility window starts from the date the most recent doctoral degree was completed. E.g., the window for Ph.D. candidates starts from the date of successful dissertation defense; the window for M.D., Ph.D. candidates starts with the most recent of the internship completion or successful dissertation defense dates.
Submission Requirements and Deadlines
Prospective applicants must complete a letter of intent (LOI) using an online portal.
Step 1: REGISTRATION IS NOW CLOSED
Registrations must be submitted no later than 3:00 PM EDT on September 26, 2022. You will receive portal login details and LOI forms. Deadline extensions will not be allowed.
Step 2: Log in to the portal to complete the LOI and upload required forms, including:
- Fellow’s Eligibility Details, Publications, Presentations, and Posters
- Fellow’s Biographical Sketch and Mentor’s Biographical Sketch and List of Fellows Supervised
- Resources and Environment Form
- Signature Form
LOIs will be reviewed by amfAR staff to verify applicant eligibility. The qualifications of eligible applicants will be assessed by peer review. The best-qualified eligible applicants will be invited to submit complete applications proposing original research to be conducted during the phase I fellowship period.
The LOI and application selection process are highly competitive. Only a limited number of investigators submitting an LOI will be invited to submit an application, and only a limited number of applicants will be awarded funding. Submission of an LOI does not guarantee an invitation to submit a full application. An invitation to submit a full application is not a guarantee of funding.
- Maximum Funding: $150,000 including maximum 10% indirect costs
- Salary support is allowed for fellow only at a maximum of $100,000 for the two-year period; percent effort on the fellowship project must be at least 85%; additional funds needed to support salary for effort at that level must come from other non-project specific sources available to the institution.
- The balance of direct costs is available to support research costs, fringe benefits, and employer taxes.
- The grantee Institution is required to provide funds or in-kind support to enhance the career development of the fellow (CFAR development funds; mentoring program; reduced-rate use of core facilities; etc.). The Institution must provide support for attendance at an NIH grant-writing workshop, or a similar training activity approved in advance by amfAR.
- Phase II funding for an additional $50,000 may be approved, at a later date, to support biomedical HIV/AIDS research costs during the first 12 months of an independent research position at any US or international nonprofit research institution.
- Phase II funding can start any time during the Phase I performance period, or up to six months following the end of the Phase I period.
Other Important Dates
Mid-November 2022 (tentative)
Mid-December 2022 (tentative)
Funding decisions announced:
Please email firstname.lastname@example.org with any questions about this RFP.
Stay informed regarding future requests for proposals
Click here to sign up for e-mailed Grant Opportunity announcements.